Inventor
RAYMON HEATHER
US17 patents
⚠️ This page may combine multiple inventors who share the name “RAYMON HEATHER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGNAL PHARM LLC
16 patentsUS9512124B2Dec 6, 2016
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC32 citations96
US9737541B2Aug 22, 2017
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC12 citations91
US9505764B2Nov 29, 2016
Treatment of cancer with dihydropyrazino-pyrazines
SIGNAL PHARM LLC11 citations83
US9493466B2Nov 15, 2016
Treatment of cancer with TOR kinase inhibitors
SIGNAL PHARM LLC7 citations83
US10940152B2Mar 9, 2021
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC1 citations72
US10646493B2May 12, 2020
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC1 citations72
US9782427B2Oct 10, 2017
Methods for treating cancer using TOR kinase inhibitor combination therapy
SIGNAL PHARM LLC3 citations72
US9630966B2Apr 25, 2017
Treatment of cancer with dihydropyrazino-pyrazines
SIGNAL PHARM LLC4 citations71
US11166950B2Nov 9, 2021
Treatment of cancer with TOR kinase inhibitors
SIGNAL PHARM LLC0 citations62
US9937170B2Apr 10, 2018
Treatment of cancer with TOR kinase inhibitors
SIGNAL PHARM LLC1 citations62
US11590139B2Feb 28, 2023
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC0 citations61
US10391092B2Aug 27, 2019
Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
SIGNAL PHARM LLC0 citations51
US10183019B2Jan 22, 2019
Treatment of cancer with dihydropyrazino-pyrazines
SIGNAL PHARM LLC0 citations51
US9980963B2May 29, 2018
Treatment of cancer with dihydropyrazino-pyrazines
SIGNAL PHARM LLC0 citations51
US9937169B2Apr 10, 2018
Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
SIGNAL PHARM LLC0 citations51
US10576085B2Mar 3, 2020
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC0 citations37